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Abstract
Background: The use of cold plasmas may improve the surface roughness of poly(lactic-co-glycolic) acid (PLGA) 
membranes, which may stimulate the adhesion of osteogenic mediators and cells, thus accelerating the biodegrada-
tion of the barriers. Moreover, the incorporation of metallic-oxide particles to the surface of these membranes may 
enhance their osteoinductive capacity. Therefore, the aim of this paper was to evaluate the reliability of a new PLGA 
membrane after being treated with oxygen plasma (PO2) plus silicon dioxide (SiO2) layers for guided bone regenera-
tion (GBR) processes. 
Material and Methods: Circumferential bone defects (diameter: 11 mm; depth: 3 mm) were created on the top of 
eight experimentation rabbits’ skulls and were randomly covered with: (1) PLGA membranes (control), or (2) PLGA/
PO2/SiO2 barriers. The animals were euthanized two months afterwards. A micromorphologic study was then per-
formed using ROI (region of interest) colour analysis. Percentage of new bone formation, length of mineralised bone, 
concentration of osteoclasts, and intensity of ostheosynthetic activity were assessed and compared with those of the 
original bone tissue. The Kruskal-Wallis test was applied for between-group com asignificance level of a=0.05 was 
considered. 
Results: The PLGA/PO2/SiO2 membranes achieved the significantly highest new bone formation, length of miner-
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alised bone, concentration of osteoclasts, and ostheosynthetic activity. The percentage of regenerated bone supplied 
by the new membranes was similar to that of the original bone tissue. Unlike what happened in the control group, 
PLGA/PO2/SiO2 membranes predominantly showed bone layers in advanced stages of formation. 
Conclusions: The addition of SiO2 layers to PLGA membranes pre-treated with PO2 improves their bone-regeneration 
potential. Although further research is necessary to corroborate these conclusions in humans, this could be a promis-
ing strategy to rebuild the bone architecture prior to rehabilitate edentulous areas.
Key Words: Guided bone regeneration (GBR), poly(lactic-co-glycolic acid) (PLGA), membrane; oxygen plasma 
(PO2), nanocomposite, silicon dioxide layers.
Introduction 
Silicon is an essential trace element in humans and one 
of the twelve major elements that are present in the or-
ganisms. Nowadays, Tissue engineering, Biomedicine, 
and Odontology are working to design new biomaterials 
that can be modified with this element at the nanometric 
scale to mimic the original tissues’ structure in addition 
to providing a stable support for the extracellular matrix 
(1-3). These investigations are revolutionizing the clas-
sical techniques encompassed in the concept of guided 
bone regeneration (GBR) that were traditionally based 
on the use of physical barriers to prevent the gingival 
epithelium and connective tissue cells from invading 
the bone cavity during the healing process (4), and even 
the scattering of the graft particles in surgical manipu-
lations (5). 
PLGA is a synthetic biomaterial formed by poly(lactic-
co-glycolic) acid copolymer that can be resorbed by 
the human body without generating an immune rejec-
tion reaction (6). PLGA membranes have demonstrated 
a correct efficiency, adhesion, and vascularisation of 
the surrounding tissues (1). Although these polymers 
are hydrophobic (3), which decreases their mechani-
cal resistance, facilitates the release of acid residues, 
diminishes the pH, and favours the bacterial prolifera-
tion and inflammatory responses; the functionalisation 
of their surfaces with cold plasma may fairly overcome 
these drawbacks (2,7). On the one hand, the use of cold 
plasmas may improve the surface roughness of PLGA 
membranes, which may stimulate the adhesion of os-
teogenic mediators and cells, thus accelerating the bio-
degradation of the barriers (2,7,8). On the other hand, 
the incorporation of thin layers, such as metallic oxides, 
may optimise the osteoinductive capacity of these mem-
branes. This may facilitate the adherence of osteblasts 
and the functional differentiation by regulating specific 
genes that participate in the neogenesis of the minera-
lised matrix (2,9-11). 
Our research describes a new method based on the in-
corporation of silicon dioxide (SiO2) layers (through 
‘dry way’ apposition) onto PLGA membranes modified 
with oxygen plasma (PO2) to increase the bone-regener-
ation potential of this biomaterial. Even though the pilot 
study included a group of PLGA/PO2/SiO2 barriers (3), 
the present investigation represents a major advance, 
as the pilot evaluation only showed data trends with-
out statistical significance. In the current study, bigger 
bone defects were created (with double diameter). This 
increased the difficulty for filling the defects and made 
the histological differences between groups more evi-
dent. A greater sample size of rabbits was used (almost 
three times larger than that of the pilot trial). Unlike 
in the pilot experiment, a double marking technique 
was applied (with calcein) to assess the length of min-
eralised bone formed in the grown defects, and two es-
sential parameters of bone regeneration were compared 
with those of the original bone tissue (i.e., percentage of 
new bone formation, and concentration of osteoclasts/
mm2). Many authors have also utilised parietal bone 
of rabbits for related purposes (3,12-14). The calvarial 
bone and the maxillary/mandible bone have comparable 
membranous embryological origins, as both are derived 
from the neural crest (13). Nonetheless, the findings of 
animal studies that use parietal bone should be always 
considered as a previous necessary step to be corrobo-
rated in prospective investigations that use human max-
illary bone and long healing periods. 
The aim and novelty of this prospective cohort animal 
study were, therefore, to in vivo evaluate the bone-
regeneration capacity of PLGA membranes treated 
with PO2 and sputtered with nanometric layers of SiO2, 
which may act as osteogenic mediators (15). This might 
be useful to properly restore bone dimensions in prepa-
ration for naturally appearing dental prostheses. The 
null hypothesis tested was that the functionalisation of 
PLGA membranes with the described method does not 
affect their bone regeneration efficacy.
Material and Methods
1.1. Preparation of the polymeric PLGA membranes
Sixteen 40-µm-thick, resorbable organic PLGA barriers 
based on poly(lactic-co-glycolic) acid copolymer were 
fabricated from a 1.5 wt% PLGA dichloromethane solu-
tion by evaporation of the solvent on a teflon plate at the 
Institute of Materials Science of Seville (ICMSE, Spain). 
The membranes were used to cover the bone defects 
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prepared on the parietal bone of eight experimental rab-
bits’ skulls. Two groups of regenerative membranes (n = 
2 each) were prepared and tested for GBR processes: 1: 
PLGA (control) and 2: PLGA/PO2/SiO2. The thickness 
of the SiO2 coatings ranged from 20 to 40 nm. 
The control group was characterised by X-ray photo-
emission spectroscopy (XPS) so that 54% carbon and 
46% oxygen were registered on the membranes’ sur-
faces. The molecular weight of the PLGA copolymer 
was 12 kDa. The PLGA was synthesised by means of 
the ring-opening copolymerisation of two different 
monomers, the cyclic dimers (1,4-dioxane-2,5-diones) 
of glycolic acid, and lactic acid. During polymerisation, 
successive monomeric units (of glycolic or lactic acid) 
were attached in PLGA by ester linkages, thus yield-
ing linear, aliphatic polyester. The C1s spectrum of the 
bare PLGA consisted of three well-defined bands at 
284.6, 287.5 and 288.5 eV; these bands are attributed to 
C-C/C-H, COO, and the COR functional groups of the 
composite polymer. 
In the Group 2, the treatment of PLGA substrates with 
PO2 took place at close to ambient temperatures (RT, 
room temperature: 23.0 ± 1.0 ºC) and did not affect their 
structural integrity. The membranes’ surfaces were ex-
posed to pure oxygen plasma in a low pressure radio 
frequency (RF) parallel plate reactor working at 13.56 
MHz and 10 W for 1 min. This physical/etching tech-
nique improved the surface roughness of the barriers 
and favoured the adhesion of future coatings. The mem-
branes were then covered with thin bioactive layers of 
SiO2 with nominal thickness of 20-40 nm (by means 
of ‘dry way’ procedures) to prevent contact between 
the polymer and liquid. This process was carried out at 
RT, by Plasma-Enhanced Chemical Vapor Deposition 
(PECVD) in a remote configuration system that con-
sisted of an external microwave plasma source (SLAN, 
Plasma Consult, GMbh, Germany) separated 10 cm 
from the reactor chamber by a grounded grid to avoid 
the microwave heating of the barriers. The reactor was 
operated at 400 W under a total pressure of 4 × 10-3 
Torr during deposition, with pure O2 as plasma gas, and 
hexamethyldisiloxane (HDMSO) as a precursor. Some 
of the co-authors patented this new formula for GBR 
processes (González-Padilla D, García-Perla-García A, 
Gutiérrez-Pérez JL, Torres-Lagares D, Castillo-Dalí 
G, Salido-Peracaula M, et al. (inventors): Membrana 
reabsorbible para regeneración ósea. Spanish patent: 
P-0201232018, 2012). A diagram of this set of proce-
dures was shown in our pilot study (3).
1.2. Animal experimentation specimens
An a priori power calculation made from the data ob-
tained in the pilot study (3) provided the sample size 
required to achieve statistical significance in the main 
investigation (α = 0.05, β = 0.2). Thus, eight white, male, 
New Zealand-breed experimentation rabbits with iden-
tical characteristics (age: 6 ± 0.5 months; weight: 3.5 ± 
0.5 kg) were selected for the study and fed daily with 
rabbit-maintenance Harlan-Teckland Lab Animal Diets 
(2030). Four dental surgeons, a veterinarian, a support-
ing anaesthesiologist, a biologist, nurses, and specialised 
clinical assistants participated in the surgical interven-
tions, which were carried out at the Minimally Invasive 
Surgery Centre Jesús Usón (CCMI, Cáceres, Spain) in 
September 2015 (time of day: 9 a.m.). This experiment 
complies with the World Medical Association (WMA) 
Statement on Animal Use in Biomedical Research (ad-
opted by the 41st World Medical Assembly celebrated in 
Hong Kong in 1989, revised by the 57th WMA General 
Assembly celebrated in South Africa in 2006, and reaf-
firmed by the 203rd WMA Council Session celebrated in 
Buenos Aires in 2016); with the EU Directive 2010/63/
EU about the protection of animals used for scientific 
purposes; with the EU Directive 86/609/EEC regarding 
the care and use of animals for experimentation; with 
the National Institutes of Health guide for the care and 
use of Laboratory animals (NIH Publications No. 8023, 
revised in 1978); and with the Spanish laws and regula-
tions. This research obtained the approval of the Ethics 
Committee of the University of Seville (Spain). As stat-
ed by the legislative framework, the minimum number 
of animals was utilised for ethical reasons. 
1.3. Surgical procedure
The animals were first immobilised, and their vital signs 
were checked. In order to avoid animal pain and suffer-
ing, intravenous midazolam (0.25 mg/kg), and propo-
fol (5 mg/kg) were administered as anaesthetics for 
induction. For maintenance, the animals inhaled 2.8% 
inspired sevoflurane gas. Analgesia was provided with 
ketorolac (1.5 mg/kg), and tramadol (3 mg/kg). Once 
the rabbits were sedated and prepared, both incisions 
between the bases of their ears, and between their eyes, 
were performed with a No. 15 scalpel blade and were 
connected with another incision made on the skull mid-
line, so that a triangular field was discovered. The epi-
thelial, connective, and muscular tissues were displaced 
using a Pritchard periosteotome. The skull surface was 
washed with a sterile saline solution with aspiration. 
Two bone defects (diameter: 11 mm; depth: 3 mm) were 
created on the parietal bone, on each side of the skull 
midline, 3 mm apart, using a trephine (Ref. 08.910.12, 
Helmut-Zepf Medical Gmbh, Seitingen-Oberflacht, 
Germany) mounted on an implant micromotor operat-
ing at 2,000 rpm under saline irrigation (Fig. 1). Ac-
cording to the manufacturer, the trephine characteris-
tics were: internal diameter of 10 mm; sheath of 2.35 
mm × 30 mm in length; and 19 teeth graduation. As the 
defects were created in a symmetric fashion in relation 
to the longitudinal axis of each skull, possible between-
groups variations in section thickness were minimised. 
For each defect, the outer table and the medullar bone 
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were completely removed with piezosurgery, and the in-
ner table was preserved to avoid damage to the brain 
tissue (5). The depth was controlled with a periodontal 
probe, while the thickness of the bone pieces was mea-
sured with a millimetre rule. 
One membrane of each group was randomly assigned 
to cover the bone defects of each rabbit. The randomi-
sation sequence was generated using specific software 
(Research Randomizer, V. 4.0, Urbaniak GC & Plous 
S, 2013; http://www.randomizer.org/). The PLGA fi-
bres of the barriers were also randomly oriented. The 
membranes were fixed with the fibrin tissue adhesive 
Tissucol (Baxter, Hyland S.A. Immuno, Rochester, MI, 
USA), which was placed on the bone rims adjacent to 
the defects. Proper adhesion and limited mobility of the 
membranes was confirmed when the flaps were moved 
back to their initial positions. Sutures were made on the 
following planes using resorbable material: periosteal 
(4/0), sub-epidermal (4/0), and skin (2/0). Simple stitch-
es were used as close as possible to the edge. The op-
eration lasted for about 1 h per specimen. The wound 
was carefully cleaned with a sterile saline solution. 
Anti-inflammatory analgesia (buprenorphine 0.05 mg/
kg, and carprofen 1 ml/12.5 kg) was administered. The 
animals were sacrificed two months after surgery using 
an intravenous overdose of potassium chloride solution. 
Samples were obtained from the skull of each rabbit, 
cutting them in an anatomical sagittal plane (Fig. 2). 
After the brain mass was separated and the skull was 
washed with a sterile saline solution, the tissue samples 
were cut, marked individually, and set in 70% alcohol 
before being handled in the laboratory of histology. 
More illustrative images of the surgical procedure can 
be found in the latest publications of our group (3,14).
1.4. Processing of samples
The skull samples were processed for histological anal-
ysis at the Dental School of the Paris-Descartes Univer-
sity (1EA 2496, Montrouge, France). The protocols of 
Gallina et al. (12) and Torres-Lagares et al. (13) were 
strictly followed to complete the tissue fixation. After 
immersion in alcohol, the skull samples were fixed in 
a cold (4 ºC) 70% ethanol solution. Once dehydrated, 
the samples were embedded without demineralisation 
in methyl methacrylate (MMA) blocks (Merck, Darm-
stadt, Germany) which were set horizontally and per-
pendicularly to the sagittal axis, and polished in a con-
ventional machine. Histological 5-µm-thick sections 
were cut using the Jung Ultrafrase Polycut E microtome 
(Reichert-Jung K, Leica, Heidelberg, Germany). To 
minimise the variance in thickness among the speci-
mens, the slices were obtained from the middle region 
of the bone defects in series of ten slices each, placed on 
glass sample holders pre-treated with albumin, and set 
in 80% ethanol. The original bone disks were prepared 
for histology.
1.5. Staining and morphometric study
To evaluate the percentages of new bone formation, a 
metachromatic dye for histological staining and rapid 
contrast tissue analysis (Merck Toluidine Blue Merck, 
Darmstadt, Germany) (TB) was used. A 1% toluidine 
blue (TB) solution with a pH of 3.6 was adjusted with 
HCl 1 N. The samples were exposed to the dye for 10 
min at RT, rinsed with distilled water, and air-dried. The 
von Kossa (VK) silver nitrate technique (Sigma-Aldrich 
Chemical Co., Poole, UK) was applied to visualise the 
mineralised bone. 
To quantify the length of mineralised bone formed in 
the grown defects, intravenous labelling with calcein/
demeclocycline in a 5% physiologic serum was carried 
out one week and one day before sacrifice. The reactives 
were calcein disolved into 2% NaHCO3 in serum (ref. 
SIGMA C0875 1 g, Sigma-Aldrich, USA), and deme-
clocycline hidroclorhide (ref. SIGMA A6140 5 g). The 
administration included 30 mg/kg of calcein (using 9 
mg calcein/mL) for each rabbit (i.e., 45 mg for an animal 
of 1.5 kg) eight days before sacrifice. For each rabbit, 
45 mg calcein was combined with 5 mL physiologic se-
rum and 0.1 g NaHCO3; the VT was 5 mL per animal. 
Fig. 1. Intraoperatory picture. Fig. 2.  Regenerated calvarial bone in the experimental group. Bone 
sample extracted from the skull after the healing period. 
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The administration also included 30 mg/kg of demeclo-
cycline (using 9 mg demeclocycline/mL) for each rab-
bit (i.e., 45 mg for an animal of 1.5 kg) one day before 
sacrifice. For each rabbit, 45 mg demeclocycline was 
combined with 5 mL physiologic serum; the VT was 
5 mL per animal. Each rabbit was intraperitoneally in-
jected with 5 mL of the solution. The calceine supplied 
a green colour to the new bone, and the demeclocycline 
provided a yellow colour. 
To evaluate the resorptive activity of the regenerated 
bone tissue, the enzymological technique for evidence 
of tartrate of sodium resistant acid phosphatase (TRAP) 
was developed. This hydrolase served as a cytochemi-
cal marker for osteoclasts and pre-osteoclasts released 
into the surrounding environment during bone resorp-
tion to facilitate bone dissolution (16). The samples’ 
slices were incubated in Naphthol ASTR phosphate 
(Sigma-Aldrich), which was previously dissolved in NN 
dimethylformamide. Then, a 0.1 M buffer of acetate so-
dium tartrate and Fast Red TR salt hemi (zinc chloride) 
(Sigma-Aldrich) were added, the pH was adjusted to 
5.2, and the final solution was filtered. The slices were 
incubated at 37 ºC for 1 h in the dark. 
To investigate the ostheosynthetic activity of the re-
generated tissues, the technique of evidence of alkaline 
phosphatase (ALP) was applied for osteoblasts and pre-
osteoblasts. The slices were pre-incubated for 10 min in 
0.1% Tris Triton (Sigma-Aldrich), washed in 0.1 M Tris 
hydrochloride, and incubated in the dark at 37 ºC for 
30 min in Naphthol ASTR phosphate together with the 
coloured reaction developer Fast Blue RR Salt (Sigma-
Aldrich) as a coupler (with adjusted pH = 9). A weak 
colouring of 1% TB was diluted to 10% in distilled wa-
ter to give the samples contrast. Cells marked in violet, 
which defined the dimensions of the samples’ osteogen-
ic strip, were considered as positive results. 
As described in the previous subsection, the TRAP 
and ALP staining were performed on resin (methyl-
methacrylate) embedded samples to achieve better 
preservation of the trabecular bone structure (17-19). An 
improved MMA embedding method was applied (18), 
thus circumventing the decalcification procedure (19). 
These were the differences with respect to the original 
method: (a) Instead of dehydration of the bone samples 
with acetone (17), we used a standard dehydration pro-
tocol. Overall, acetone fixation causes massive shrink-
age artefacts and acetone dehydration results in inferior 
quality of the bone section. (b) The infiltration protocol 
allowed achieving optimal infiltration of the tissue with 
the plastic. Good infiltration is the basis for uniform po-
lymerisation and high section quality. (c) The addition 
of methylbenzoate to the methacrylate solution during 
infiltration and polymerisation improved preservation 
of antigenicity of the tissue. (d) Methylbenzoate acts 
as a plasticizer in MMA embedding mixtures. (e) The 
amount of the accelerator N,N-dimethyl-p-toluidine 
used for chemical polymerisation at low temperatures 
has been reduced, as recommended (18), resulting in a 
lower tendency for bubble formation and more homoge-
neous polymerisation of the blocks. (f) This procedure 
does not require purification and destabilization of the 
methacrylates used for infiltration and polymerisation 
(17-19). 
The morphometric study of the bone was carried out 
by means of a Zeis Axioscop II microscope (Axioscop 
40, Goettingen, Germany) using 4×, 10×, and 20× lens-
es. Pictures were taken with a digital signal processor 
(DSP) 3CCD camera (Sony, Tokyo, Japan), and Inteli-
cam 8.0 software (Smart Matrox Imaging, Montreal, 
Canada). To quantify the newly regenerated tissue and 
to compare it with the original bone tissue, an assess-
ment from distal (external) to proximal (internal) was 
made using ROI (region of interest) colour analysis with 
specific software (Fiji Is Just ImageJ, Tokyo, Japan). 
The following parameters were assessed by a different, 
blinded operator: percentage of new bone formation, 
length of mineralised bone formed daily in the grown 
defects (mm/day), concentration of osteoclasts (number 
of osteoclasts/mm2), and intensity of bone ostheosyn-
thetic activity.
1.6. Statistical analysis
Mean and standard deviations (SD) were calculated for 
each quantitative parameter. The intra-examiner reli-
ability was examined using the Kappa test (20). Since 
the Kolmogorov-Smirnov test demonstrated that the 
data were not normally distributed, the non-parametric 
Kruskal-Wallis test was run for post hoc comparisons 
(14). The level of significance was set in advance at a = 
0.05 (12,13,16,20). The Statview F 4.5 Macintosh soft-
ware (Abacus Concepts, Berkeley, CA, USA) was util-
ised for the analysis (3).
Results
For each experimental group of membranes, all of the 
animals were included in each analysis (8/8). The im-
planted biomaterials of both groups tested were well tol-
erated by the surrounding soft tissues, with no evidence 
of allergy symptoms, immune reactions, necrosis, or in-
compatibility after the healing period. The main study 
findings are illustrated in table 1, and in figure 3 (a-j). 
All of the images correspond to the superficial part of 
the regenerated bone. As the surgeon removed all of the 
bone except for the inner table (i.e., the outer table and 
the medullar bone were completely removed), the imag-
es show the new bone formed in a cranio-caudal direc-
tion. The Kappa statistic shows a perfect intra-examiner 
reliability (k = 1) for all of the evaluations performed 
(percentage of new bone formation, length of minera-
lised bone formed, concentration of osteoclasts, and in-
tensity of ostheosynthetic activity). 
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The PLGA/PO2/SiO2 barriers confirmed higher propor-
tion of dense and thick endocranial and exocranial cor-
tical bone tissue when compared with the control group 
in the histological slices (Fig. 3a,b). Moreover, the study 
group and the original bone showed similar proportion 
of dense cortical bone tissue.  Marrow and adipose-like 
tissues were more detectable in the untreated PLGA 
scaffolds, whereas the PLGA/PO2/SiO2 membranes ex-
hibited only a little adipose-like surrounding tissue. The 
histological evaluation therefore suggested some asso-
ciation between the appearance of this kind of tissue 
and the modification of the membranes’ surfaces. 
In the TB analysis, the control group demonstrated less 
formation of new bone than did the PLGA/PO2/SiO2 
group (Fig. 3a,b). As a result of the VK test, the experi-
mental group achieved significantly higher percentage 
of new bone formation than did the controls (p = 0.039) 
(Fig. 3c,d). In this aspect, the functionalised group and 
the original bone were comparable, meaning that the 
control group showed the significantly lowest formation 
of new bone in the study (p  < 0.05) (Table 1). 
The study group evidenced higher length of mineralised 
bone formed in the grown defects when compared with 
the control group, as it was interpreted from the calcein 
images (0.065 ± 0.015 mm/day vs. 0.032 ± 0.005 mm/
day, respectively; p  = 0.034) (Figs. 3e,f). In these imag-
es, the distance between lines was measured. The green 
line (injected eight days before euthanasia) is very clear, 
while the yellow one (injected 24 h before euthanasia) 
is faint. Hence, the bone edge was used instead to make 
the calculations.  
With regard to the TRAP analysis, the experimental 
group exhibited significantly higher concentration of 
osteoclasts than did the control group (p  = 0.0039) (Fig. 
3g,h). Nonetheless, the original bone tissue demonstrat-
ed significantly higher concentration of these cells than 
did the PLGA/PO2/SiO2 group (p  = 0.005) (Table 1). 
Unlike the control group, both the study group, and the 
original bone tissue showed more than 2 osteoclasts per 
mm2. 
The ALP technique attributed the highest ostheosyn-
thetic activity to the study group. The blue linear distri-
bution of osteogenic cells on the bone surface was more 
evident in the modified membranes (Fig. 3i,j). 
Discussion
Our results require the rejection of the null hypothesis, 
as the functionalised barriers demonstrated significantly 
higher bone regeneration potential than did the simple 
PLGA membranes when assessed as the combination 
of formation of new bone, length of bone formed daily 
in the grown defects, concentration of osteoclasts, and 
intensity of ostheosynthetic activity (Table 1, Fig. 3). 
The PLGA-based scaffolds were easy to use and handle, 
and showed no displacement after implantation. These 
membranes demonstrated high biocompatibility, since 
no immune reaction, symptomatology of allergies, ab-
normal swelling, intolerance by the underlying soft tis-
sues, or evidence of necrosis was detected in any group 
(3,14). There is enough evidence in the literature re-
marking that the results of bone regeneration are worse 
in the absence of a GBR membrane (5,21,22). Incom-
plete bone formation (21), lower height of the restored 
bone, and bone defects partially filled by the overlying 
soft and dense fibrous tissues (5,22) are frequently found 
in these cases. Simple PLGA barriers were thus selected 
instead as the control group. Furthermore, the treatment 
of PLGA membranes with oxygen plasma (PO2) clearly 
NEw BONE FORMATION AND CONCENTRATION OF OSTEOCLASTS
PLGA (control) PLGA/PO2/SiO2 ORIGINAL BONE
                               NEw BONE FORMATION (%)
Mean ± SD 29.97 % ± 1.88 b 39,72 % ± 3,53 a 41.9 % ± 3.85 a
Difference (OB - NB) -12.73 % ± 4.5 d +2.90 % ± 9.3 c
                         OSTEOCLASTS/MM2
Mean ± SD (osteoclasts/mm2) 9.08 ± 0.5 c
  
13.58 ± 0.85 b 21.48 ± 1.7 a
Difference (OB - NB) -12.42 ± 1.0 e - 7.92 ± 3.1 d
Table 1. New bone formation and concentration of osteoclasts. 
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improved the histological results when compared with 
those barriers that were directly coated with inorganic 
films of silicon dioxide particles (PLGA/SiO2) in our 
pilot study (3). While direct deposits of SiO2 particles 
seem to generate a flattening effect (3,23), the physical 
pre-treatment with PO2 increases the surface roughness 
of the PLGA biomaterial (23); which promotes the ad-
hesion of osteogenic mediators. This is crucial, since 
osteoblasts and other molecules that grow anchored to 
an extracellular matrix (ECM) require to be bonded to 
the substrate before starting a normal function (24). The 
roughening effect generated by the plasma treatment al-
lows signalling from the ECM to nucleus via integrins, 
cytoskeleton, and molecular cascades (i.e., G-proteins, 
kinases, and ions). This attraction of osteogenic cells 
and particles also assists the degradation of the barriers, 
thus favouring the bone regeneration (8,23). The effect 
of the plasma treatment itself (which was not the focus 
of our experiment) has been extensively documented 
(8,23). Even though the PO2 was basically applied in the 
study group to prepare the membranes’ surfaces for im-
proving the retention of the SiO2 particles, it might have 
somehow affected the bone regeneration process (3,14).
The stimulating effect of silicon on the proliferation, and 
differentiation of osteoblastic cells has been confirmed 
(9,10,15). Silicon has been described as an important 
element of osteogenesis, as it seems to enhance the os-
teoblasts’ potential for reparation and mineralization in 
the damaged tissues where it is implanted (25). Recent 
studies have even demonstrated that through providing 
osteoporotic patients with silicate supplements instead 
of biphosphonates, a major increase of the femur and 
back bone density levels may be observed (25,26). SiO2-
nanocomposite particles could therefore act as primer 
initiators for the synthesis of a mineral bone matrix 
(15), expediting the healing and repair of bone defects 
(14). Even though the effect of this new material on the 
differentiation of osteoblasts by the regulation of osteo-
specific genes involved in the neogenesis of the min-
eralized matrix deserves further investigation (24), in 
this research, the combination of oxygen plasma and sil-
ica oxide apposition for the functionalisation of PLGA 
membranes supplied the best results of bone regenera-
tion (Table 1; Fig. 3). 
Concerning the histological analysis, dense layers of 
exocranial and endocranial mature bone in rather ad-
vanced stages of formation were found in those defects 
that were covered with PLGA/PO2/SiO2 membranes. 
Conversely, greater proportions of marrow and adipose-
like tissues surrounded the bare PLGA barriers. This 
micromorphology is characteristic in immature tissues, 
retard phases, or initial-growing phases when the GBR 
membranes are not active enough (3). However, when the 
scaffolds are functionalised with active nanoparticles, 
such as SiO2, only a few marrow and adipose like tis-
sues are detected (3,14) (Table 1; Fig. 3a,b). Future studies 
should confirm this correlation between the type of bar-
rier and the presence of immature tissues (7,27,28).
Overall, the advantages of PLGA membranes mainly 
depend on their structural design and topography; which 
may increase their adhesive potential, enhance the osteo-
Fig. 3. Morphometric analysis made under microscope at 2 months 
of follow-up. (a) TB image of the control group showing the lowest 
proportion of new bone formation. (b) TB image of the study group 
exhibiting bone in an advanced stage of formation. (c) VK image 
of the control group. (d) VK image of the study group confirming a 
larger formation of dense bone (Figs.: 2a-d; objective: 4×; bar: 250 
µm; zoom: 1.5). (e) Calcein image of the control group. (f) Calcein 
image of the experimental group containing higher length of minera-
lised bone between the bone edge and the green line (Figs. 2e,f; ob-
jective: 20×; bar: 50 µm; zoom: 1.5). (g) TRAP image of the control 
group. (h) TRAP image of the study group with higher concentration 
of osteoclasts. (i) ALP image of the control group. (j) ALP image 
of the study group evidencing the highest ostheosynthetic activity 
(Figs.: 2g-j; objective: 5×; bar: 250 µm; zoom: 1.5). 
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blasts’ ability to migrate and bond at the cell-substrate 
interphase, and help direct and organise the adhesion 
and differentiation of bone cells to facilitate proper tis-
sue repair (29). The calcein test yielded the most conclu-
sive evidence in this regard, revealing that the lineal rate 
of newly mineralised bone formed daily in the grown 
defects (30) doubled when PLGA/PO2/SiO2 membranes 
were used (Fig. 3e,f). The TB (Fig. 3a,b), and the VK 
analysis (Fig. 3c,d) attributed the highest percentage of 
new bone formation to the PLGA/PO2/SiO2 scaffolds, 
which showed comparable levels to those of the origi-
nal bone tissue (Table 1). Two months after surgery, the 
process of bone healing was still active, and the remod-
elling phase became noticeable. The TRAP test (Fig. 
3g,h) confirmed the existence of multinucleated giant 
cells (which act as energy reserves for trauma regenera-
tion) (28), mainly in the case of the functionalised barri-
ers. The TRAP analysis detected a significantly higher 
concentration of osteoclasts in the functionalised group 
when compared to the controls. However, the original 
bone exhibited the highest number of osteoclasts/mm2 
in the study (Table 1). Finally, the ALP analysis con-
firmed higher ostheosynthetic activity when the treated 
membranes were used to cover the bone defects (Table 
1; Fig. 3i,j). This fact, which is inherent in regenerative 
processes (3), was an indicator of the osteoconductive 
capacity of the SiO2 nanocomposite particles, and re-
vealed the migration of osteoblasts to the inner defects 
(28). For ensuring an adequate osteosynthesis, bone 
must be continuously destroyed and regenerated so 
that a proper equilibrium of the activity of osteoblasts 
and osteoclasts is achieved (14). Thus, PLGA/PO2/SiO2 
membranes confirmed greater bone regeneration capac-
ity than did PLGA barriers in view of the results of the 
four variables tested (Table 1; Fig. 3). 
These four variables disclosed comparable results in 
a related animal experiment that compared functiona-
lised PLGA/PO2/TiO2 GBR membranes with the same 
controls (14). Notwithstanding that either SiO2 or TiO2  
nanocomposite particles could act as exciters of the sur-
rounding osteoblast and pre-osteoblast cells; the induc-
tion of changes in nuclear morphology, gene transcrip-
tion, and cells’ phenotypic expression caused by each 
type of inorganic coating, and the way in which this fact 
may contribute to bone regeneration in the long term 
still remain uncertain and should be examined and con-
trasted in future investigations. 
Apart from the limitations that are inherent to any ani-
mal model when the tested material is designed for be-
ing utilised in humans, the use of parietal bone may be 
the main limitation of this study. The sample size was 
previously calculated in order to reduce the number of 
animals for ethical reasons. Moreover, the membranes 
were randomly assigned to the bone defects, and a 
blinded operator performed the morphologic study. De-
spite the fact that the apposition of SiO2 nanoparticles 
onto PO2 pre-treated PLGA membranes seems to be a 
promising new formula for GBR processes that could 
help in guaranteeing appropriate support and aesthet-
ics of our prosthodontic rehabilitations, these barriers 
should be tested in human maxillary bone before being 
recommended. 
The following conclusions may be drawn from the pres-
ent study: (1) the incorporation of silica dioxide layers 
onto PLGA membranes modified with PO2 improves the 
results of bone regeneration in both quantity and quality 
when applied to skull defects in an animal model; (2) the 
addition of SiO2 nanoparticles to PLGA membranes’ sur-
faces stimulates the new bone formation, mineralisation, 
and ostheosynthetic activity, when compared to simple 
PLGA scaffolds (actually, the functionalised substrates 
promoted similar degrees of new bone formation than 
those of the original bone tissue); (3) together with the 
requisite of more animal studies, further steps should be 
taken for investigating the application of these modified 
membranes in humans to restore bone dimensions, thus 
optimising the functional features and the natural ap-
pearance of our future prosthetic restorations.
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